In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
7 weeks 5 days ago
11 weeks 6 days ago
12 weeks 6 days ago
12 weeks 6 days ago
34 weeks 8 hours ago
38 weeks 1 day ago
39 weeks 5 days ago
39 weeks 6 days ago
1 year 10 hours ago
1 year 5 weeks ago